나이관련 황반변성에 대한 동서의학적 고찰

키워드

참고문헌 (43)

1. "3 Blindness diseases: diabetic retinopathy, macular degeneration, glaucoma", Health Josun, 11, pp.60~ (2010)
2. Friedman DS, "Prevalence of age-related macular degeneration in the United States", Arch Ophthalmol, 122, pp.564~572 (2004)
3. Lee KH, "The study of the etiological cause of blurred vision and blindness", Daejun Univ Institution of oriental medicine, 4(1), pp.1~25 (1995)
4. Chen YH, "Age-related macular degeneration: genetic and environmental factors of disease", Mol Interv, 10(5), pp.271~281 (2010)
5. Seo CH, "A case report", J Korean Oriental Med, 21(4), pp.260~263 (2000)
6. 박규형, "국내의 나이관련황반변성에 대한 기초역학조사", 대한안과학회지, 51(4), pp.516~523 (2010), 대한안과학회
7. Bressler NM, "Early detection and treatment neovascular age-related macular degeneration", J Am Board Fam Pract, (15), pp.142~152 (2002)
8. Gehrs KM, "Age-related macular degenerationemerging pathogenetic and therapeutic concepts", Ann Med, 38, pp.450~471 (2006)
9. Smith W, "Risk factors for age-related macular degeneration:pooled findings from three continetns", J Ophthalmology, 108, pp.697~704 (2001)
10. Swaroop A, "Unravelling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisnms for age-related macular degeneration", Annu Rev Genomics Hum Genet, 10, pp.19~43 (2009)
11. Hirvela H, "Risk factors of age-related maculopathy in a population 70 years of age or older", J Ophthalmology, 103, pp.871~877 (1996)
12. Klein R, "Relation of smoking to the incidence of age-related maculopathy–The Beaver Dam Eye Study", 147, pp.103~110 (1998)
13. Seddon JM, "Dietary fat and risk for advanced age-related macular degeneration", Arch Ophthalmol, 119, pp.1191~1199 (2001)
14. Montezuma SR, "Review of genetics in age related macular degeneration", Semin Ophthalmol, 22, pp.229~240 (2007)
15. Klein R, "Small Drusen and Age-Related Macular Degeneration:The Beaver Dam Eye Study", J Clin Med, 4(3), pp.424~440 (2015)
16. 한소영, "삼출성 나이관련황반변성 환자들의 삶의 질에 대한 평가", 대한안과학회지, 53(4), pp.528~535 (2012), 대한안과학회[DOI]
17. 정지원, "한국인 나이관련황반변성 환자의 우울 및 불안에 대한 조사 및 그 영향에 대한 고찰", 대한안과학회지, 53(6), pp.792~800 (2012), 대한안과학회[DOI]
18. Göbel AP, "Imaging geographic atrophy in age-related macular degeneration", Ophthalmologica, 226, pp.182~190 (2011)
19. Lindblad AS, "Change in area of geographic atrophy in the age-related eye disease study:AREDS report No 26. Arch Ophthalmol", Arch Ophthalmol, 127, pp.1168~1174 (2009)
20. Schmitz-Valckenberg S, "Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy", Am J Ophthalmol, pp.183~192 (2008)
21. Haimovici R, "Localization of lipoprotein-delivered benzoporphyrin derivatiove in the rabbit eye", Curr Eye Res, 16, pp.83~90 (1997)
22. Schmidt-Erfurth U, "Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors", Exp Eye Res, 62, pp.1~10 (1996)
23. Miller H, "Photodynamic theraphy of subretinal neovascularization in the monkey eye", Arch Ophthalmol, 111, pp.855~860 (1993)
24. 조두영, "맥락막신생혈관을 동반한 삼출성 나이관련황반변성 환자에서 광역학치료 후 10년간의 경과관찰", 대한안과학회지, 53(1), pp.59~67 (2012), 대한안과학회
25. Brown DM, "Ranibizumab versus verteporfin for neovascular age-related macular degeneration", N Engl J Med, 355(14), pp.1432~1444 (2006)
26. Rosenfeld PJ, "Ranibizumab for neovascular age-related macular degeneration", N Engl J Med, 355(14), pp.1419~1431 (2006)
27. 장효주, "나이관련황반변성에 동반된 맥락막신생혈관에서 유리체내 라니비주맙 주사의 2년 장기 효과", 대한안과학회지, 54(9), pp.1359~1364 (2013), 대한안과학회
28. 조윤정, "출혈우세병변이 동반된 연령관련 황반변성 환자에서의 유리체강 내 라니비주맙 주입술의 효과", 대한안과학회지, 52(7), pp.838~845 (2011), 대한안과학회
29. Avery RL, "Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration", Ophthalmology, 113(3), pp.363~372 (2006)
30. David L, "Cellular models and therapies for age-related macular degeneration", Dis Model Mech, 8(5), pp.421~427 (2015)
31. 김모세, "삼출성 노인황반변성에 대한 치료 후 발생한망막색소상피파열의 임상결과", 대한안과학회지, 54(10), pp.1540~1545 (2013), 대한안과학회
32. 박재홍, "연령관련황반변성의 혈관내피성장인자억제제 주사치료 후 발생한망막색소상피파열의 장기 경과관찰", 대한안과학회지, 55(9), pp.1340~1346 (2014), 대한안과학회
33. 최우석, "연령관련황반변성에서 유리체강내 혈관내피성장인자억제제주입술 후 망막색소상피파열의 위험인자", 대한안과학회지, 54(10), pp.1546~1553 (2013), 대한안과학회
34. 김종민, "신생혈관성 나이관련황반변성 환자에서 1차 루센티스 안내주사 후 발생한 전층황반원공 1예", 대한안과학회지, 54(7), pp.1130~1134 (2013), 대한안과학회
35. Ford KM, "Expression and role of VEGF-A in the ciliary body", Invest. Ophthamol. Vis. Sci, 53, pp.7520~7527 (2012)
36. Saint-Geniez M, "Endogenous VEGF is required for visual function: evidence for a survival role on Müuller cells and photoreceptors", PLoS ONE, 3(11), pp.e3554~ (2008)
37. Kim SY, "Retinal phagocytes in age-related macular degeneration", Macrophage (Houst), 2(1) (2015)
38. Buschini E, "Recent developments in the management of dry age-related macular degeneration", Clin Ophthalmol, 9, pp.563~574 (2015)
39. Smailhodzic D, "Zinc supplementation inhibits complement activation in age-related macular degeneration", PLoS One, 9(11) (2014)
40. 길현경, "초기 황반변성 환자에서 들쭉 추출물의 효과", 대한안과학회지, 54(8), pp.1255~1260 (2013), 대한안과학회
41. Heo J, "Donguibogam", pp.635~ (2009), Bubinmunhwasa
42. Ko WS, "Korean Medicine Ophthalmology", pp.40~41 (2015)
43. Noh SS, "Korean Medicine Ophthalmology, Otolaryngology, dermatology", pp.339~ (2011), Seoul Inshuaesa

관련 논문AI추천